GA
Geneva Advisors’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $91.2M | Buy |
771,536
+2,000
| +0.3% | +$236K | 1.57% | 12 |
|
|
2017
Q1 | $72.4M | Sell |
769,536
-114,520
| -13% | -$10.8M | 1.29% | 20 |
|
|
2016
Q4 | $82.8M | Sell |
884,056
-9,129
| -1% | -$855K | 1.62% | 12 |
|
|
2016
Q3 | $108M | Buy |
893,185
+21,731
| +2% | +$2.62M | 2.02% | 8 |
|
|
2016
Q2 | $86.9M | Buy |
871,454
+27,087
| +3% | +$2.7M | 1.72% | 11 |
|
|
2016
Q1 | $74.5M | Buy |
844,367
+251,924
| +43% | +$22.2M | 1.5% | 16 |
|
|
2015
Q4 | $46.8M | Buy |
592,443
+302,461
| +104% | +$23.9M | 0.9% | 37 |
|
|
2015
Q3 | $41.2M | Buy |
289,982
+66,247
| +30% | +$9.42M | 0.83% | 42 |
|
|
2015
Q2 | $31.9M | Buy |
223,735
+2,623
| +1% | +$374K | 0.57% | 60 |
|
|
2015
Q1 | $31.5M | Buy |
221,112
+213,065
| +2,648% | +$30.4M | 0.57% | 60 |
|
|
2014
Q4 | $1.03M | Sell |
8,047
-171
| -2% | -$21.8K | 0.02% | 292 |
|
|
2014
Q3 | $839K | Hold |
8,218
| – | – | 0.02% | 341 |
|
|
2014
Q2 | $705K | Buy |
8,218
+77
| +0.9% | +$6.61K | 0.01% | 371 |
|
|
2014
Q1 | $604K | Buy |
8,141
+48
| +0.6% | +$3.56K | 0.01% | 355 |
|
|
2013
Q4 | $532K | Sell |
8,093
-5,343
| -40% | -$351K | 0.01% | 324 |
|
|
2013
Q3 | $936K | Sell |
13,436
-1,275
| -9% | -$88.8K | 0.02% | 259 |
|
|
2013
Q2 | $989K | Buy |
+14,711
| New | +$989K | 0.02% | 221 |
|